CHECKMATE GOVERNMENT RELATIONS

Lobbying for NOVO NORDISK, INC. · Pharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · $90,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

There is no current bill filed. Issues related to anti-obesity medications, drug pricing, and pharmaceutical supply chain.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.